Why Attend?

Agenda
CLE

A virtual format will enable innovative learning opportunities, increased schedule flexibility, and a new level of interaction between regulatory practitioners, industry experts, and government officials. Speakers will analyze the latest commercial issues related to advertising and promotion of human and animal drugs, medical devices, and biologics

Practical Takeaways: Sessions will explore updated government agency initiatives, goals, and priorities, product promotion in a remote environment, social media best practices, trends in pre- approval communications, effective patient engagement, and litigation risks.

Government Speakers: Representatives from various FDA Centers, the Federal Trade Commission, the Department of Health and Human Services Inspector General, and the Department of Justice will provide the latest information on policy, enforcement, and future initiatives.

Peer Interaction: The conference will prioritize virtual learning, engagement, and networking with fellow legal, regulatory, and marketing experts.

Register

 

Industry & Firms

$1499
  • +$400 for non-members

Non-Profit

$799
  • +$100 for non-members

Government

$799
  • +$100 for non-members

Academic

$799
  • +$100 for non-members

Student

Free

Sponsors

Sponsorship opportunities are available. Please let us know if you would like more information.

Gold Sponsor

 

Gold Sponsor

 

Gold Sponsor

 

Gold Sponsor

 

Gold Sponsor

 

Gold Sponsor

 

Silver Sponsor

 

 

Silver Sponsor

Silver Sponsor

 

Silver Sponsor

Bronze Sponsor

 

Bronze Sponsor

 

Planning Committee

Co-Chairs

Madhavi Bellamkonda, Intuitive Surgical Inc.
Bryant M. Godfrey
, Foley Hoag LLP

 

Committee

Rebecca Burnett, Framework Solutions
Julie B. Chronis, Gilead Sciences, Inc.
Mary Ellen Dronitsky, Northeastern University
Virginia Foley, Opus Regulatory, Inc.
Mark Gaydos, Sanofi
Matthew Hegreness, Covington & Burling LLP
Mark Levy, Eckert Seamans Cherin & Mellott, LLC
Lauren A. Miller, AbbVie
Thomas Miller, Nixon GWILT Law
Gillian M. Russell, King & Spalding LLP
Victoria Tamarkin, Tamarkin Consulting LLC
Kyle Thomson, American Medical Association
Ashley Zborowsky, Medtronic

 

Call for Proposals

FDLI and the Conference Planning Committee thanks those who participated in the Call for Proposals this spring. The input received from industry stakeholders helps us plan a timely program. If you submitted a proposal, you will be notified of the status of your proposal in early July.